Skip to main content
. Author manuscript; available in PMC: 2024 May 7.
Published in final edited form as: Lancet Oncol. 2023 Apr 17;24(5):468–482. doi: 10.1016/S1470-2045(23)00147-X

Table 3:

AEs occurring in at least 10% of participants at any grade, or in at least 1% of participants at Grade 3–5

CRT n(%) CRT+ACT n (%)
Adverse event Grad e 1–2 Grad e 3 Grad e 4 Grad e 5 Grad e 1–2 Grad e 3 Grad e 4 Grad e 5 P-value*
Abdominal pain 179 (40) 16 (4) 175 (48) 19 (5) 0.0086
Alanine aminotransferase increased 77 (17) 3 (1) 1 (0) 98 (27) 2 (1) 0.0020
Alopecia 40 (9) 284 (79) 1 (0) <.0001
Anemia 259 (57) 34 (8) 1 (0) 238 (66) 66 (18) <.0001
Anorexia 138 (30) 5 (1) 129 (36) 2 (1) 0.21
Anxiety 62 (14) 1 (0) 76 (21) 1 (0) 0.020
Arthralgia 40 (9) 1 (0) 79 (22) 1 (0) <.0001
Aspartate aminotransferase increased 46 (10) 2 (0) 1 (0) 84 (23) 2 (1) <.0001
Back pain 111 (25) 5 (1) 96 (27) 4 (1) 0.79
Constipation 204 (45) 1 (0) 1 (0) 192 (53) 1 (0) 0.067
Creatinine increased 57 (13) 4 (1) 1 (0) 59 (16) 3 (1) 0.30
Cystitis noninfective 102 (23) 6 (1) 95 (26) 6 (2) 0.40
Dehydration 40 (9) 14 (3) 50 (14) 9 (2) 0.071
Depression 57 (13) 1 (0) 70 (19) 2 (1) 1 (0) 0.012
Dermatitis radiation 64 (14) 1 (0) 64 (18) 1 (0) 0.37
Diarrhea 323 (71) 21 (5) 277 (77) 21 (6) 0.064
Dizziness 53 (12) 1 (0) 65 (18) 2 (1) 0.028
Dysgeusia 58 (13) 60 (17) 0.12
Dyspnea 58 (13) 3 (1) 1 (0) 78 (22) 3 (1) 0.0037
Dysuria 54 (12) 58 (16) 0.088
Edema limbs 49 (11) 2 (0) 52 (14) 0.14
Fatigue 361 (80) 8 (2) 327 (91) 9 (2) <.0001
Febrile neutropenia 8 (2) 1 (0) 9 (2) 0.63
Female genital tract fistula 10 (2) 6 (1) 2 (0) 6 (2) 5 (1) 0.78
Fever 32 (7) 54 (15) 3 (1) 0.0001 7
Headache 94 (21) 1 (0) 103 (29) 0.025
Hearing impaired 47 (10) 51 (14) 4 (1) 0.019
Hemorrhage Bladder 76 (17) 7 (2) 54 (15) 5 (1) 0.76
Hemorrhage Rectum 62 (14) 2 (0) 65 (18) 1 (0) 0.23
Hot flashes 106 (23) 115 (32) 2 (1) 0.0066
Hyperglycemia 41 (9) 8 (2) 3 (1) 58 (16) 7 (2) 3 (1) 0.0087
Hypertension 28 (6) 17 (4) 45 (12) 12 (3) 0.0077
Hypoalbuminemia 54 (12) 1 (0) 67 (19) 2 (1) 0.021
Hypocalcemia 56 (12) 3 (1) 58 (16) 1 (0) 0.24
Hypokalemia 69 (15) 11 (2) 4 (1) 65 (18) 17 (5) 0.30
Hypomagnesemia 100 (22) 2 (0) 2 (0) 111 (31) 6 (2) 0.0096
Hyponatremia 62 (14) 3 (1) 46 (13) 12 (3) 0.019
Insomnia 96 (21) 1 (0) 104 (29) 0.030
Kidney infection 1 (0) 5 (1) 3 (1) 0.62
Lymphocyte count decreased 114 (25) 167 (37) 41 (9) 77 (21) 179 (50) 32 (9) 0.0012
Menopause 8 (2) 12 (3) 5 (1) 16 (4) 0.35
Myalgia 52 (11) 141 (39) 3 (1) <.0001
Nausea 335 (74) 14 (3) 296 (82) 11 (3) 0.016
Neutrophil count decreased 84 (19) 27 (6) 7 (2) 117 (32) 61 (17) 10 (3) <.0001
Pain 41 (9) 3 (1) 44 (12) 3 (1) 0.33
Pain in extremity 94 (21) 3 (1) 123 (34) 2 (1) 0.0001 1
Pelvic pain 146 (32) 11 (2) 138 (38) 8 (2) 0.20
Peripheral motor neuropathy 19 (4) 72 (20) 4 (1) <.0001
Peripheral sensory neuropathy 130 (29) 1 (0) 271 (75) 16 (4) <.0001
Platelet count decreased 140 (31) 3 (1) 2 (0) 192 (53) 14 (4) 2 (1) <.0001
Premature menopause 11 (2) 1 (0) 17 (5) 0.11
Proctitis 49 (11) 2 (0) 34 (9) 0.36
Sepsis 1 (0) 8 (2) 1 (0) 3 (1) 0.32
Small intestinal obstruction 1 (0) 5 (1) 1 (0) 8 (2) 1 (0) 0.31
Syncope 2 (0) 5 (1) 4 (1) 5 (1) 0.51
Thrombosis/Thrombus/Embolism 19 (4) 7 (2) 18 (5) 5 (1) 2 (1) 0.78
Tinnitus 84 (19) 87 (24) 1 (0) 0.079
Urinary frequency 92 (20) 84 (23) 0.31
Urinary incontinence 69 (15) 68 (19) 1 (0) 0.20
Urinary tract infection 63 (14) 17 (4) 1 (0) 51 (14) 17 (5) 0.87
Urinary tract obstruction 1 (0) 10 (2) 1 (0) 8 (2) 0.99
Urinary tract pain 45 (10) 1 (0) 56 (16) 0.039
Urinary urgency 40 (9) 44 (12) 0.12
Vaginal discharge 167 (37) 147 (41) 0.26
Vaginal dryness 56 (12) 53 (15) 1 (0) 0.33
Vaginal hemorrhage 164 (36) 8 (2) 1 (0) 133 (37) 7 (2) 1 (0) 0.95
Vaginal pain 65 (14) 3 (1) 47 (13) 2 (1) 0.84
Vaginal stricture 57 (13) 10 (2) 39 (11) 5 (1) 0.49
Vomiting 165 (36) 11 (2) 166 (46) 15 (4) 0.0042
Weight loss 46 (10) 6 (1) 52 (14) 6 (2) 0.16
White blood cell decreased 80 (18) 16 (4) 3 (1) 74 (20) 31 (9) 7 (2) 0.00066
*

Chi-square test comparing none vs. mild vs. severe between arms